The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Tampere University Hospital
Sponsor:
Information provided by:
Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT00766103
First received: October 2, 2008
Last updated: November 25, 2013
Last verified: November 2013
  Purpose

Incidence of hypo- and hypercarbia during induced hypothermia after cardiac arrest is high. The original report from HACA-group reported that hypothermia treated patients had improved survival and neurological outcome. Suprisingly, in that trial normocarbia was not achieved even though the aim was set for ventilatory support as normoventilation. This study aims to investigate the effects of mild hypo- and hypercarbia on cerebral perfusion (blood flow, intracranial pressure) and metabolism (microdialysate metabolites). We hypothesize that uncontrolled ventilatory suppport may render the patients in risk of exacerbation of neuronal damage, conversely, further improvement in outcome may be achieved with succesfull ventilatory management. We intend to enroll 10 out-of-hospital cardiac arrest patients succesfully resuscitated and subsequently treated with controlled hypothermia for 24 hours. The patients in need of anticoagulation are excluded. We plan to induce mild hypocarbia and hypercarbia during and after induced hypothermia. Metabolic and perfusion data are collected with clinically used methods such as transcranial doppler, intracranial pressure measurement, near infrared spectroscopy, jugular bulb, intracerebral microdialysis).


Condition Intervention
Cerebral Metabolism and Perfusion
Other: mild hypo- and hyperventilation

Study Type: Interventional
Official Title: The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

Resource links provided by NLM:


Further study details as provided by Tampere University Hospital:

Primary Outcome Measures:
  • surrogate physiological endpoints

Arms Assigned Interventions
crossover: hypo- and hypercarbia Other: mild hypo- and hyperventilation
induction of mild hypo- and hypercarbia

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

succesfull resuscitation of out of hospital cardiac arrest, primary rhytm shockable

Exclusion Criteria:

  • known coagulopathy, need of anticoagulation therapy, need of interventional cardiological procedures
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00766103

Contacts
Contact: Jyrki J Tenhunen, MD, PhD +358500677195 jyrki.tenhunen@pshp.fi
Contact: Patrik RH Falkenbach, MD +358405604636 patrik.falkenbach@pshp.fi

Locations
Finland
Critical Care Medicine Research Group/ department of intensive care Recruiting
Tampere, Pirkanmaa, Finland, 33521
Contact: Jyrki J Tenhunen, MD, PhD    +358500677195    jyrki.tenhunen@pshp.fi   
Contact: Patrik RH Falkenbach, MD    +358405604636    patrik.falkenbach@pshp.fi   
Sub-Investigator: Patrik RH Falkenbach, MD         
Principal Investigator: Jyrki J Tenhunen, MD, PhD         
Sub-Investigator: Antti Kämäräinen, MD         
Sponsors and Collaborators
Tampere University Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Critical Care Medicine Research Group, Tampere University Hospital
ClinicalTrials.gov Identifier: NCT00766103     History of Changes
Other Study ID Numbers: R06213
Study First Received: October 2, 2008
Last Updated: November 25, 2013
Health Authority: Finland: Ministry of health

Keywords provided by Tampere University Hospital:
Cerebral metabolism, perfusion, induced hypothermia

Additional relevant MeSH terms:
Hypothermia
Body Temperature Changes
Signs and Symptoms

ClinicalTrials.gov processed this record on July 24, 2014